Applied StemCell
Milpitas
About Applied StemCell
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus on the development and commercialization of: Mouse models (Knockin, Knockout, Transgenic, Site-specific transgenic - TARGATT™, Humanized mouse models) Rat models Human cell line model (Gene modified iPSC - adult stem cell / progenitor cells - differentiated cells) Stem cell culture products (optimized stem cell medium and reporters) Gene engineering in stem cells or other mammalian cells (e.g. generation of protein - production mammalian cell lines) We are striving to improve and expand our technologies and product lines to meet the increasing requirements of biomedical community. ASC welcomes your comments, suggestions and ideas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $23.5M
- Funding stage: M&A
- Last round: Series D (Jun 2016)
- Website: appliedstemcell.com
- Phone: +114087738007
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/applied-stemcell-53723 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.